Feng Wei

Fzata, Inc.

NIH Rank #3230
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.7M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#3,230
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.7M across 2 grants · National rank #3230.

Top grants by award amount

Feng Wei's NIH grant portfolio, ranked by award amount.

  • 1UG3NS135350-01A1UG3
    A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome
    $2.1M
    award amount
  • 5R01DE029946-05R01
    Disruption of Homeostatic Neuroimmune Interactions in Descending Circuitry in the Development of Pain Chronicity
    $586.7K
    award amount

Affiliations

Institutions that have administered grants for Feng Wei.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Fzata, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3230
  6. 2024
    Entered Top 25% Nationally
    Ranked #3230
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Feng Wei.